Non-Compliance with Growth Hormone Treatment in Children
Author Information
Author(s): Wayne S. Cutfield, José G. B. Derraik, Alistair J. Gunn, Kyle Reid, Theresa Delany, Elizabeth Robinson, Paul L. Hofman
Primary Institution: Liggins Institute, University of Auckland, Auckland, New Zealand
Hypothesis
What is the compliance rate of children and adolescents with growth hormone treatment in New Zealand?
Conclusion
Non-compliance with growth hormone treatment is common and associated with reduced linear growth in children.
Supporting Evidence
- 66% of patients were non-compliant with their GH treatment.
- Patients with good compliance had significantly greater linear growth.
- Maori ethnicity was associated with a lower rate of compliance.
Takeaway
Many kids in New Zealand don't take their growth hormone medicine as they should, which can make them grow less.
Methodology
A national survey assessed GH compliance in children receiving government-funded GH over a four-month period.
Potential Biases
Caregiver-reported compliance may overestimate adherence due to social desirability bias.
Limitations
The return of used GH vials was not mandatory, which may have led to underestimation of compliance.
Participant Demographics
Patients were 12.1 years old on average, with 48% males; 75% identified as European & other, 15% Maori, 7% Asian, and 4% Pacific Islander.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website